Prospective observational study shows improved visual and anatomical outcomes in diabetic macular edema, suggesting beneficial effects of therapy.
Anti-VEGF therapy led to significant changes in both BCVA and CST at 12 months (P < 0.001). Younger patients, shorter duration of diabetes and NPDR were associated with improved results. The visual and anatomic improvements were sustained over the full duration of the study.
No takes yet. Share an insight, caveat, or question.
Priya et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: